NXD-02

N/A

Report date: 2024/11/12 15:24:11
NME

Base Information

Drug NameNXD-02
Drug Alias NameNXD02NXD-02
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionApoptosis regulator Bcl-X degraders
TargetsApoptosis regulator Bcl-X
Therapy Area/IndicationsSmall Cell Lung CarcinomaOvarian NeoplasmsLymphoma, T-Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Neox Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Neox Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaOvarian NeoplasmsLymphoma, T-Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A